Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord Mesenchymal Stem Cells for Diabetic Erectile Dysfunction
NCT04972890Phase 3Unknown
- Sponsor
- Universitas Indonesia
- Start
- Oct 2020
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of human umbilical cord mesenchymal stem cells in erectile dysfunction (ED) (2 arms), sponsored by Universitas Indonesia. Primary endpoints: International Index of Erectile Function-5 Score at 3 months, Peak Systolic Velocity at 3 months and 8 more. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT04972890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04972890.